A1 Refereed original research article in a scientific journal
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Authors: Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Norgaard M, Nielsen RB, Zoega H, Valdimarsdottir U
Publisher: AMER MEDICAL ASSOC
Publication year: 2013
Journal: JAMA: Journal of the American Medical Association
Journal name in source: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Journal acronym: JAMA-J AM MED ASSOC
Volume: 309
Issue: 1
First page : 48
Last page: 54
Number of pages: 7
ISSN: 0098-7484
DOI: https://doi.org/10.1001/jama.2012.153812
Abstract
Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.
Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.
UTU Research Portal